275 related articles for article (PubMed ID: 27723400)
21. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
22. Multi-drug therapy in leprosy: an effective method of control.
Indian J Lepr; 1984; 56(1):102-12. PubMed ID: 6548238
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
Mysore V; al-Suwaid AR
Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):159-61. PubMed ID: 10472369
[No Abstract] [Full Text] [Related]
24. THELEP controlled clinical trials in lepromatous leprosy.
Lepr Rev; 1983 Sep; 54(3):167-76. PubMed ID: 6355720
[No Abstract] [Full Text] [Related]
25. Evolution of the modern chemotherapy of leprosy.
Levy L
Lepr Rev; 1983 Jun; Spec No():69-83. PubMed ID: 6350773
[No Abstract] [Full Text] [Related]
26. Chemotherapy of leprosy for control programmes: scientific basis and practical application.
Rees RJ
Lepr Rev; 1983 Jun; 54(2):81-7. PubMed ID: 6888143
[No Abstract] [Full Text] [Related]
27. Multi-drug therapy of leprosy.
Ramu G
Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
[No Abstract] [Full Text] [Related]
28. Screening of drugs for activity against Mycobacterium leprae.
Baohong J; Matsuo Y; Colston MJ
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
[No Abstract] [Full Text] [Related]
29. Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience.
Sheetal S; Arvind C
Int J Rheum Dis; 2009 Apr; 12(1):64-9. PubMed ID: 20374320
[TBL] [Abstract][Full Text] [Related]
30. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
31. [Hansen's disease: case report and review of literature].
Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
[TBL] [Abstract][Full Text] [Related]
32. Experience with multidrug therapy in paucibacillary leprosy.
Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
[TBL] [Abstract][Full Text] [Related]
33. Remitting seronegative symmetrical synovitis with pitting edema in leprosy.
Helling CA; Locursio A; Manzur ME; Sormani de Fonseca ML
Clin Rheumatol; 2006 Feb; 25(1):95-7. PubMed ID: 16175431
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of treatment of lepromatous leprosy patients in the Netherlands.
Faber WR; Leiker DL
Dermatologica; 1979; 158(1):46-54. PubMed ID: 367843
[TBL] [Abstract][Full Text] [Related]
35. Care after cure in leprosy.
John TJ; Muliyil J
Lancet; 2001 Jan; 357(9252):313. PubMed ID: 11214161
[No Abstract] [Full Text] [Related]
36. Multidrug therapy in leprosy.
Manglani PR; Arif MA
J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
[TBL] [Abstract][Full Text] [Related]
37. Effect of zafirlukast on leprosy reactions.
Vides EA; Cabrera A; Ahern KP; Levis WR
Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):71-5. PubMed ID: 10407633
[No Abstract] [Full Text] [Related]
38. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
[TBL] [Abstract][Full Text] [Related]
39. [Sensory-motor neuropathy: a slow and misleading case of leprosy].
Gabelle A; Vallat JM; Flageul B; Andre P; Camu W
Rev Neurol (Paris); 2008 Nov; 164(11):964-8. PubMed ID: 18808760
[TBL] [Abstract][Full Text] [Related]
40. [Leprosy – an old infectious disease with unsolved matters].
Stock I
Med Monatsschr Pharm; 2016 Dec; 39(12):522-6. PubMed ID: 29979513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]